Scandinavia based EntomoPharm was established in 2009 with the mission to provide customers with cost efficient insect based ADME models for early drug discovery. EntomoPharm is the only contract research organization specializing in preclinical ADME in insects.
Aspiring to help clients accelerate their mission in drug development, EntomoPharm provides quality services for pharmaceutical and biotech companies around the world.
EntomoPharm is the only contract research organization specializing in preclinical ADME assays based on insects. The insect assays can be used to screen small-molecule compounds to identify BBB properties of drug leads in both CNS drug development and in safety risk identification for peripherally acting drugs.
The experienced team of scientists provides clients with unique competences within ADME modeling in insects and each client project can be designed to meet specific customer needs:
- Delivery upon repetitive compound submission for screen projects
- Delivery upon intermittent compound submission.
- Fast track delivery
- Extended scientific support